800 million yuan cross-border acquisition
800 million yuan This time, Shengxiang Bio has set its sights directly on the field of biologics in the pharmaceutical […]
800 million yuan This time, Shengxiang Bio has set its sights directly on the field of biologics in the pharmaceutical […]